Department of Neurology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Front Cell Infect Microbiol. 2021 Jul 16;11:698807. doi: 10.3389/fcimb.2021.698807. eCollection 2021.
is a Gram-positive opportunistic pathogen that could cause pneumonia and bacteremia in stroke patients. The development of antibiotic resistance in hospital-associated is a formidable public health threat. Bacteriophage therapy is a renewed solution to treat antibiotic-resistant bacterial infections. However, bacteria can acquire phage resistance quite quickly, which is a significant barrier to phage therapy. Here, we characterized a lytic bacteriophage Vb_EfaM_LG1 with lytic activity. Its genome did not contain antibiotic resistance or virulence genes. Vb_EfaM_LG1 effectively inhibits growth for a short period, and phage resistance developed within hours. However, the combination of antibiotics and phage has a tremendous synergistic effect against , prevents the development of phage resistance, and disrupts the biofilm efficiently. Our results show that the phage-antibiotic combination has better killing efficiency against .
是一种革兰氏阳性机会致病菌,可引起中风患者的肺炎和菌血症。医院获得性 对抗生素的耐药性发展是一个严峻的公共卫生威胁。噬菌体疗法是一种新的方法来治疗抗生素耐药性细菌感染。然而,细菌可以很快获得噬菌体抗性,这是噬菌体治疗的一个重大障碍。在这里,我们描述了一种具有裂解活性的裂解性 噬菌体 Vb_EfaM_LG1。它的基因组不包含抗生素耐药性或毒力基因。Vb_EfaM_LG1 可以在短时间内有效地抑制 生长,并且噬菌体抗性在数小时内产生。然而,抗生素和噬菌体的联合使用对 具有巨大的协同作用,可以防止噬菌体抗性的产生,并有效地破坏生物膜。我们的结果表明,噬菌体-抗生素联合使用对 具有更好的杀伤效率。